Shahrzad Zarghamee, MD
Nephrology · Los Altos
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 15
- 3 carriers
- Office
- 1
Offices
1 location · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Hospitals listed: 552746 · 552756 · 752582 · El Camino Health · Mills-Peninsula Medical Center · Stanford Health Care · Sutter Roseville Medical Center. That is not proof they admit you there this week.
Plans that list them
15 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Zarghamee’s office at (650) 254-5200 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
15 of 15 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence G83906 · Current
Licensed to practise in California · since 1997 · expires 2027-05-31 · University of Wisconsin Medical School.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
4 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
- Peninsula Medical CenterBurlingame, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.139, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.242, Oct 2024 – Sep 2025
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
- Sutter Roseville Medical CenterRoseville, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 79% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Pressure ulcer rate: 0.08 (0 to 0.56) · 12,400 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.069, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.262, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.128, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.357, Oct 2024 – Sep 2025
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Peninsula Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.139 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.242 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.21 (0.27 to 2.15) · 1,258 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.81 (0.51 to 1.1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 155.44 (112.67 to 198.21) · 90 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.5 · 32 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 82 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10 · 188 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9 · 473 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.8 · 342 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.4 · 485 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 3,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.4) · 6,904 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,052 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.41 (1.43 to 5.39) · 1,695 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.72 (0.17 to 3.28) · 665 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,545 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.1 (1.3 to 12.9) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.96 (2.63 to 9.29) · 653 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.15 to 3.08) · 418 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.14 (0 to 0.78) · 5,539 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.7 · 192 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.215 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.263 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.74 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 300 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19 · 702 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 1.2 · 207 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -13.6 · 531 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 24.3 · 343 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.1 · 449 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.5 (2.8 to 7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.6 (6.7 to 13.7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.7 · 189 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11 · 45 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.6 · 117 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (9.7 to 17.2) · 584 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 764 cases | No different | Jan 2024 – Dec 2024 |
What patients said (523 patients answered, 27% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for Sutter Roseville Medical Center
Behind the star rating — Deaths: 2 better, 5 the same, 0 worse of 7 measures. Safety: 5 better, 1 the same, 1 worse of 7 measures. Readmissions: 2 better, 7 the same, 1 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Pressure ulcer rateComplications and deaths | 0.08 (0 to 0.56) · 12,400 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.069 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.262 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.128 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.357 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.33 (0.49 to 2.17) · 2,916 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.9 (0.63 to 1.17) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 147.2 (107.33 to 187.07) · 191 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.9 · 250 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.7 · 484 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.4 · 839 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.3 · 1,027 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10 · 656 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.8 · 6,822 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.25 (0.08 to 0.42) · 14,300 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.06 to 0.41) · 14,490 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.43 (2.77 to 6.08) · 3,117 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.38 (0 to 2.95) · 938 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.06 (0.76 to 3.36) · 2,944 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.03 (2.8 to 15.25) · 840 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.43 (3.11 to 9.75) · 899 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.73 (0.34 to 3.11) · 819 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.4 · 35 cases | None | Apr 2023 – Mar 2025 |
| SSI - Colon SurgeryInfections | 0.41 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.9 · 527 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.6 · 1,094 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -16.6 · 443 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -11 · 961 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -8 · 1,064 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.1 · 1,293 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.5 (3.5 to 8.7) · 35 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.2 (6.9 to 14.9) · 35 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 36 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 18.5 · 310 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.8 to 17.9) · 116 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.7 to 1) · 1,600 cases | No different | Jan 2024 – Dec 2024 |
What patients said (537 patients answered, 24% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 74% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 62% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 70% |
| Doctors "always" listened carefully | 76% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 77% |
| Staff "always" explained new medications | 77% |
| Nurses "always" explained things so they could understand | 78% |
| Nurses "always" listened carefully | 75% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 52% |
| "YES", patients would definitely recommend the hospital | 79% |
| Staff "always" explained possible side effects | 47% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$283,389
Medicare paid this office $283,389 for 446 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 255 | $79,453 | $113 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 100 | $45,981 | $106 |
| Dialysis services, 1 physician visit per month (20 years or older) | 30 | $31,526 | $189 |
| Home dialysis services per month (20 years or older) | 14 | $31,440 | $264 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 17 | $19,438 | $270 |
See all 12 services
| Return visit (30+ min) | 255 | $79,453 | $113 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 100 | $45,981 | $106 |
| Dialysis services, 1 physician visit per month (20 years or older) | 30 | $31,526 | $189 |
| Home dialysis services per month (20 years or older) | 14 | $31,440 | $264 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 17 | $19,438 | $270 |
| Short return visit (20+ min) | 146 | $17,856 | $77 |
| Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 11 | $17,599 | None |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 85 | $15,372 | $154 |
| Long return visit (40+ min) | 56 | $13,770 | $158 |
| Telephone medical discussion with physician, 21-30 minutes | 30 | $3,762 | $102 |
| New patient visit (45+ min) | 21 | $3,351 | $160 |
| Injection of drug or substance under skin or into muscle | 11 | $634 | $14 |
Who their Medicare patients are
446 Original Medicare patients in 2024. Average age 77 · Under 65 8% · 85 and older 26% · Women 46% · Also on Medicaid 22% · Health risk score 2.93. At or below the middle of the specialty; the typical nephrology clinician is at 4.01.
Conditions among them: High blood pressure 75% · Chronic kidney disease 75% · Diabetes 53% · Coronary heart disease 42% · Heart failure 36% · Atrial fibrillation 31% · Depression 22% · Cancer 21% · COPD 17% · Dementia 13% · Stroke 13%.
The office billed $1,104,230, Medicare allowed $370,045 and paid $283,389; for 9,643 services of 19 kinds; $17,599 of it was for drugs given in the office and $265,790 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 446 | 9,643 | 77 | 2.93 | $1,104,230 | $283,389 |
| 2023 | 435 | 7,628 | 77 | 3.07 | $1,000,832 | $275,852 |
| 2022 | 450 | 5,840 | 77 | 2.99 | $965,858 | $282,792 |
| 2021 | 426 | 4,107 | 76 | 2.94 | $886,276 | $269,867 |
| 2020 | 452 | 10,622 | 76 | 3.14 | $1,022,076 | $282,309 |
| 2019 | 454 | 8,017 | 76 | 3.31 | $982,632 | $267,111 |
| 2018 | 467 | 15,128 | 75 | 3.07 | $1,095,439 | $290,925 |
| 2017 | 463 | 18,804 | 75 | 3.24 | $1,079,124 | $299,377 |
| 2016 | 466 | 16,097 | 75 | 3.07 | $1,133,854 | $324,723 |
| 2015 | 443 | 9,397 | 76 | 2.92 | $915,863 | $272,976 |
| 2014 | 460 | 16,549 | 75 | 3.17 | $965,662 | $276,025 |
| 2013 | 413 | 13,748 | 75 | 3.02 | $977,985 | $274,263 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 11 services
| Return visit (30+ min) | 258 | $83,105 | $115 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 100 | $50,989 | $110 |
| Dialysis services, 1 physician visit per month (20 years or older) | 32 | $30,279 | $192 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 21 | $23,453 | $276 |
| Home dialysis services per month (20 years or older) | 12 | $20,114 | $276 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 76 | $15,993 | $160 |
| Long return visit (40+ min) | 61 | $14,676 | $163 |
| Short return visit (20+ min) | 130 | $14,275 | $78 |
| Telephone medical discussion with physician, 21-30 minutes | 36 | $4,603 | $98 |
| New patient visit (45+ min) | 14 | $2,255 | $161 |
| Automated urinalysis test | 14 | $31 | $2 |
2022: 14 services
| Return visit (30+ min) | 260 | $86,979 | $120 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 113 | $49,125 | $95 |
| Dialysis services, 1 physician visit per month (20 years or older) | 31 | $28,231 | $193 |
| Home dialysis services per month (20 years or older) | 12 | $24,614 | $280 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 23 | $24,090 | $280 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 77 | $18,566 | $184 |
| Short return visit (20+ min) | 131 | $15,341 | $79 |
| Long return visit (40+ min) | 59 | $14,092 | $170 |
| Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 11 | $9,201 | None |
| Telephone medical discussion with physician, 21-30 minutes | 40 | $4,158 | $76 |
| New patient visit (45+ min) | 26 | $4,031 | $155 |
| Telephone medical discussion with physician, 11-20 minutes | 11 | $686 | $62 |
| Injection of drug or substance under skin or into muscle | 11 | $596 | $14 |
| Automated urinalysis test | 19 | $42 | $2 |
2021: 12 services
| Return visit (30+ min) | 220 | $67,506 | $120 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 28 | $37,894 | $281 |
| Dialysis services, 1 physician visit per month (20 years or older) | 37 | $36,304 | $194 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 95 | $31,907 | $96 |
| Short return visit (20+ min) | 207 | $27,980 | $78 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 74 | $18,630 | $184 |
| Long return visit (40+ min) | 43 | $10,416 | $177 |
| Telephone medical discussion with physician, 21-30 minutes | 40 | $4,617 | $92 |
| New patient visit (45+ min) | 29 | $4,501 | $155 |
| Telephone medical discussion with physician, 11-20 minutes | 31 | $1,910 | $52 |
| Short return visit | 12 | $573 | $48 |
| Automated urinalysis test | 12 | $27 | $2 |
2020: 11 services
| Return visit (30+ min) | 223 | $55,974 | $97 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 128 | $50,493 | $99 |
| Dialysis services, 1 physician visit per month (20 years or older) | 33 | $32,932 | $176 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 28 | $26,718 | $228 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 78 | $22,276 | $194 |
| Home dialysis services per month (20 years or older) | 11 | $19,830 | $228 |
| Short return visit (20+ min) | 187 | $19,708 | $66 |
| Telephone medical discussion with physician, 21-30 minutes | 108 | $16,840 | $106 |
| Telephone medical discussion with physician, 11-20 minutes | 62 | $5,281 | $70 |
| New patient visit (45+ min) | 21 | $3,052 | $145 |
| Automated urinalysis test | 12 | $27 | $2 |
2019: 7 services
| Return visit (30+ min) | 236 | $61,777 | $100 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 40 | $44,939 | $222 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 109 | $41,104 | $94 |
| Dialysis services, 1 physician visit per month (20 years or older) | 44 | $34,088 | $172 |
| Short return visit (20+ min) | 233 | $26,900 | $66 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 70 | $18,434 | $183 |
| New patient visit (45+ min) | 29 | $4,073 | $140 |
2018: 9 services
| Return visit (30+ min) | 249 | $57,715 | $93 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 44 | $52,107 | $215 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 100 | $44,376 | $94 |
| Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 15 | $38,364 | None |
| Dialysis services, 1 physician visit per month (20 years or older) | 54 | $36,082 | $162 |
| Short return visit (20+ min) | 238 | $26,125 | $64 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 55 | $14,554 | $182 |
| New patient visit (45+ min) | 48 | $6,787 | $141 |
| Injection of drug or substance under skin or into muscle | 17 | $1,709 | $20 |
2017: 11 services
| Return visit (30+ min) | 240 | $61,400 | $95 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 121 | $49,637 | $93 |
| Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 14 | $48,249 | None |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 39 | $47,297 | $216 |
| Dialysis services, 1 physician visit per month (20 years or older) | 44 | $30,239 | $166 |
| Short return visit (20+ min) | 184 | $17,166 | $62 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 67 | $15,228 | $181 |
| New patient visit (45+ min) | 40 | $5,207 | $130 |
| Dialysis services, per day, less than full month service (20 years or older) | 20 | $4,683 | $7 |
| Injection of drug or substance under skin or into muscle | 16 | $2,712 | $26 |
| Manual urinalysis test with examination using microscope, non-automated | 21 | $89 | $4 |
2016: 11 services
| Return visit (30+ min) | 258 | $72,929 | $94 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 132 | $71,017 | $93 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 35 | $40,862 | $217 |
| Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 16 | $40,613 | None |
| Dialysis services, 1 physician visit per month (20 years or older) | 49 | $31,701 | $168 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 90 | $23,614 | $180 |
| Short return visit (20+ min) | 152 | $12,909 | $62 |
| New patient visit (45+ min) | 68 | $10,163 | $149 |
| Dialysis services, per day, less than full month service (20 years or older) | 19 | $4,752 | $7 |
| Injection of drug or substance under skin or into muscle | 16 | $2,661 | $25 |
| Long return visit (40+ min) | 12 | $1,616 | $135 |
2015: 10 services
| Return visit (30+ min) | 237 | $66,237 | $97 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 110 | $55,196 | $98 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 26 | $40,287 | $226 |
| Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 14 | $21,176 | None |
| Dialysis services, 1 physician visit per month (20 years or older) | 33 | $20,422 | $172 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 69 | $16,984 | $189 |
| Short return visit (20+ min) | 170 | $16,277 | $66 |
| New patient visit (45+ min) | 54 | $8,346 | $155 |
| Dialysis services, per day, less than full month service (20 years or older) | 16 | $2,832 | $7 |
| Injection of drug or substance under skin or into muscle | 14 | $2,219 | $26 |
2014: 10 services
| Return visit (30+ min) | 276 | $86,546 | $93 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 145 | $43,781 | $92 |
| Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 21 | $40,327 | None |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 24 | $31,493 | $211 |
| Dialysis services, 1 physician visit per month (20 years or older) | 35 | $19,110 | $163 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 77 | $17,072 | $180 |
| New patient visit (45+ min) | 50 | $7,189 | $144 |
| Short return visit (20+ min) | 96 | $6,558 | $59 |
| Injection of drug or substance under skin or into muscle | 22 | $3,586 | $25 |
| Dialysis services, per day, less than full month service (20 years or older) | 13 | $3,023 | $7 |
2013: 11 services
| Return visit (30+ min) | 236 | $75,577 | $93 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 128 | $53,248 | $90 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 30 | $41,096 | $211 |
| Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 17 | $29,354 | None |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 79 | $16,127 | $175 |
| Dialysis services, 1 physician visit per month (20 years or older) | 25 | $15,216 | $164 |
| Short return visit (20+ min) | 127 | $12,519 | $63 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 11 | $5,926 | $247 |
| New patient visit (45+ min) | 37 | $5,375 | $145 |
| Dialysis services, per day, less than full month service (20 years or older) | 18 | $4,882 | $7 |
| Injection of drug or substance under skin or into muscle | 19 | $2,980 | $25 |
Medicaid work
$222 in 2024
Medicaid paid $222 for 55 billed services this clinician did in 2024, up to 13 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 42 | $136 |
| Return visit (30+ min) | 13 | $86 |
| 2024 | 55 | 2 | 13 | $222 |
| 2021 | 26 | 1 | 13 | $1,752 |
| 2020 | 24 | 1 | 12 | $1,196 |
| 2018 | 12 | 1 | 12 | $3,494 |
See the largest Medicaid services in earlier years
2021
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 1 face-to-face visit by a physician or other qualified health care professional per month | 26 | $1,752 |
2020
| Return visit (30+ min) | 24 | $1,196 |
2018
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 1 face-to-face visit by a physician or other qualified health care professional per month | 12 | $3,494 |
Drugs they prescribed that Part D paid
$331,207
Pharmacies billed $331,207 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (13 of 3,070) in 2024. Above the middle of the specialty; the typical nephrology clinician is at 0%.
2,883 generic and fewer than 11 brand-name prescriptions · $331,207 in drug cost · 80 antibiotic prescriptions to 45 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Farxiga | 41 | $58,213 | $1,420 |
| Jardiance | 36 | $54,077 | $1,502 |
| Eliquis | 20 | $20,622 | $1,031 |
| Sevelamer Carbonate | 69 | $19,174 | $278 |
| Ozempic | 11 | $9,013 | $819 |
See all 59 drugs
| Farxiga | 41 | $58,213 | $1,420 |
| Jardiance | 36 | $54,077 | $1,502 |
| Eliquis | 20 | $20,622 | $1,031 |
| Sevelamer Carbonate | 69 | $19,174 | $278 |
| Ozempic | 11 | $9,013 | $819 |
| Potassium Citrate Er | 64 | $6,257 | $98 |
| Bumetanide | 60 | $4,282 | $71 |
| Clonidine | 32 | $3,698 | $116 |
| Felodipine Er | 72 | $3,067 | $43 |
| Losartan | 143 | $2,447 | $17 |
| Midodrine | 20 | $2,196 | $110 |
| Amlodipine Besylate | 242 | $2,083 | $9 |
| Pantoprazole | 123 | $2,054 | $17 |
| Doxazosin Mesylate | 113 | $1,982 | $18 |
| Potassium Chloride | 56 | $1,734 | $31 |
| Metoprolol | 95 | $1,673 | $18 |
| Nifedipine Er | 37 | $1,669 | $45 |
| Valsartan | 37 | $1,386 | $37 |
| Labetalol | 30 | $1,192 | $40 |
| Famotidine | 52 | $1,173 | $23 |
| Olmesartan Medoxomil | 57 | $1,131 | $20 |
| Lisinopril | 108 | $1,009 | $9 |
| Tamsulosin | 64 | $937 | $15 |
| Allopurinol | 76 | $931 | $12 |
| Atorvastatin | 95 | $782 | $8 |
| Calcitriol | 91 | $759 | $8 |
| Hydralazine | 62 | $744 | $12 |
| Carvedilol | 72 | $723 | $10 |
| Mycophenolate Mofetil | 11 | $716 | $65 |
| Calcium Acetate | 12 | $632 | $53 |
| Torsemide | 15 | $612 | $41 |
| Rosuvastatin | 18 | $587 | $33 |
| Gabapentin | 21 | $496 | $24 |
| Benazepril | 27 | $467 | $17 |
| Furosemide | 92 | $439 | $5 |
| Lactulose | 21 | $426 | $20 |
| Clopidogrel | 18 | $386 | $21 |
| Spironolactone | 21 | $292 | $14 |
| Hydrochlorothiazide | 64 | $286 | $4 |
| Pravastatin | 34 | $277 | $8 |
| Ramipril | 22 | $221 | $10 |
| Metformin | 24 | $200 | $8 |
| Diltiazem 24hr Er (Cd) | 14 | $174 | $12 |
| Irbesartan | 20 | $169 | $8 |
| Finasteride | 11 | $151 | $14 |
| Prednisone | 17 | $136 | $8 |
| Metoprolol | 47 | $135 | $3 |
| Fluoxetine | 12 | $121 | $10 |
| Sertraline | 14 | $117 | $8 |
| Bupropion Xl | 12 | $112 | $9 |
| Chlorthalidone | 16 | $77 | $5 |
| Atenolol | 11 | $68 | $6 |
| Cephalexin | 21 | $65 | $3 |
| Simvastatin | 12 | $53 | $4 |
| Ciprofloxacin | 12 | $44 | $4 |
| Metformin Hcl Er | 11 | $42 | $4 |
| Triamterene-Hydrochlorothiazid | 16 | $36 | $2 |
| Zolpidem | 15 | $36 | $2 |
| Amoxicillin | 13 | $10 | $1 |
Year by year
| 2024 | 3,070 | 324 | 0% (13) | None | $331,207 |
| 2023 | 2,849 | 304 | 1% (24) | None | $379,350 |
| 2022 | 2,816 | 298 | 1% (30) | None | $355,542 |
| 2021 | 2,935 | 289 | 1% (29) | None | $303,028 |
| 2020 | 2,729 | 291 | 1% (14) | None | $272,366 |
| 2019 | 2,533 | 278 | 1% (17) | 12% | $300,368 |
| 2018 | 2,772 | 273 | 1% (33) | 13% | $416,380 |
| 2017 | 2,799 | 257 | 1% (30) | 19% | $688,967 |
| 2016 | 2,730 | 260 | 1% (21) | 18% | $623,307 |
| 2015 | 2,478 | 248 | 1% (23) | 21% | $480,804 |
| 2014 | 2,846 | 256 | 1% (29) | 25% | $419,795 |
| 2013 | 2,943 | 240 | 1% (14) | 29% | $378,121 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 54 drugs
| Renvela | 19 | $70,463 | $3,709 |
| Jardiance | 34 | $60,654 | $1,784 |
| Farxiga | 21 | $36,091 | $1,719 |
| Eliquis | 19 | $20,758 | $1,093 |
| Sevelamer Carbonate | 46 | $19,773 | $430 |
| Potassium Citrate Er | 47 | $9,731 | $207 |
| Entresto | 11 | $8,740 | $795 |
| Clonidine | 40 | $6,118 | $153 |
| Bumetanide | 48 | $4,476 | $93 |
| Potassium Chloride | 43 | $4,146 | $96 |
| Losartan | 178 | $3,519 | $20 |
| Felodipine Er | 51 | $3,509 | $69 |
| Metoprolol | 106 | $3,221 | $30 |
| Amlodipine Besylate | 195 | $3,143 | $16 |
| Doxazosin Mesylate | 99 | $3,031 | $31 |
| Pantoprazole | 98 | $2,715 | $28 |
| Prosol | 17 | $2,563 | $151 |
| Nifedipine Er | 39 | $1,958 | $50 |
| Tamsulosin | 74 | $1,745 | $24 |
| Valsartan | 35 | $1,628 | $47 |
| Lisinopril | 104 | $1,579 | $15 |
| Olmesartan Medoxomil | 40 | $1,517 | $38 |
| Atorvastatin | 91 | $1,498 | $16 |
| Labetalol | 38 | $1,398 | $37 |
| Torsemide | 15 | $1,373 | $92 |
| Hydralazine | 59 | $1,337 | $23 |
| Telmisartan | 17 | $1,336 | $79 |
| Allopurinol | 69 | $1,277 | $19 |
| Furosemide | 101 | $1,019 | $10 |
| Carvedilol | 67 | $962 | $14 |
| Calcitriol | 67 | $923 | $14 |
| Famotidine | 40 | $903 | $23 |
| Gabapentin | 22 | $769 | $35 |
| Midodrine | 11 | $709 | $64 |
| Rosuvastatin | 18 | $639 | $35 |
| Pravastatin | 32 | $602 | $19 |
| Minoxidil | 11 | $592 | $54 |
| Metoprolol | 57 | $544 | $10 |
| Clopidogrel | 23 | $502 | $22 |
| Lactulose | 22 | $477 | $22 |
| Glipizide Er | 13 | $389 | $30 |
| Clonidine | 19 | $348 | $18 |
| Hydrochlorothiazide | 48 | $340 | $7 |
| Levothyroxine | 12 | $282 | $24 |
| Benazepril | 13 | $280 | $22 |
| Ramipril | 38 | $263 | $7 |
| Triamterene-Hydrochlorothiazid | 17 | $247 | $15 |
| Metformin | 20 | $230 | $11 |
| Fluoxetine | 15 | $215 | $14 |
| Spironolactone | 14 | $170 | $12 |
| Atenolol | 16 | $120 | $8 |
| Irbesartan | 13 | $117 | $9 |
| Zolpidem | 11 | $58 | $5 |
| Amoxicillin | 11 | $23 | $2 |
2022: 58 drugs
| Renvela | 18 | $82,119 | $4,562 |
| Jardiance | 31 | $47,961 | $1,547 |
| Veltassa | 19 | $26,064 | $1,372 |
| Sevelamer Carbonate | 60 | $17,229 | $287 |
| Eliquis | 11 | $16,504 | $1,500 |
| Potassium Citrate Er | 59 | $8,259 | $140 |
| Clonidine | 42 | $7,683 | $183 |
| Vascepa | 15 | $5,239 | $349 |
| Bumetanide | 42 | $4,490 | $107 |
| Prosol | 25 | $4,130 | $165 |
| Nifedipine Er | 43 | $3,535 | $82 |
| Colchicine | 16 | $3,169 | $198 |
| Potassium Chloride | 47 | $3,077 | $65 |
| Hydralazine | 66 | $2,514 | $38 |
| Pantoprazole | 89 | $2,387 | $27 |
| Amlodipine Besylate | 211 | $2,287 | $11 |
| Felodipine Er | 48 | $2,169 | $45 |
| Doxazosin Mesylate | 105 | $2,113 | $20 |
| Rosuvastatin | 13 | $2,103 | $162 |
| Metoprolol | 89 | $1,995 | $22 |
| Losartan | 138 | $1,736 | $13 |
| Torsemide | 24 | $1,605 | $67 |
| Valsartan | 23 | $1,570 | $68 |
| Labetalol | 42 | $1,472 | $35 |
| Carvedilol | 74 | $1,398 | $19 |
| Tamsulosin | 57 | $1,395 | $24 |
| Lisinopril | 111 | $1,254 | $11 |
| Telmisartan | 14 | $1,237 | $88 |
| Allopurinol | 59 | $1,233 | $21 |
| Metolazone | 13 | $1,026 | $79 |
| Calcitriol | 61 | $893 | $15 |
| Furosemide | 119 | $818 | $7 |
| Gabapentin | 30 | $652 | $22 |
| Ondansetron | 12 | $587 | $49 |
| Famotidine | 36 | $575 | $16 |
| Atorvastatin | 68 | $567 | $8 |
| Olmesartan Medoxomil | 15 | $493 | $33 |
| Metoprolol | 40 | $434 | $11 |
| Pravastatin | 29 | $398 | $14 |
| Lactulose | 24 | $395 | $16 |
| Clopidogrel | 20 | $390 | $20 |
| Gentamicin Sulfate | 17 | $355 | $21 |
| Ramipril | 38 | $330 | $9 |
| Hydrochlorothiazide | 68 | $325 | $5 |
| Glipizide Er | 15 | $319 | $21 |
| Spironolactone | 16 | $228 | $14 |
| Triamterene-Hydrochlorothiazid | 11 | $182 | $17 |
| Irbesartan | 16 | $161 | $10 |
| Prednisone | 12 | $152 | $13 |
| Glipizide | 13 | $121 | $9 |
| Atenolol | 22 | $119 | $5 |
| Cephalexin | 14 | $111 | $8 |
| Bupropion Xl | 11 | $103 | $9 |
| Fluoxetine | 14 | $96 | $7 |
| Metformin | 17 | $58 | $3 |
| Benazepril | 19 | $48 | $3 |
| Zolpidem | 13 | $31 | $2 |
| Amoxicillin | 11 | $27 | $2 |
2021: 56 drugs
| Renvela | 38 | $83,864 | $2,207 |
| Veltassa | 17 | $22,801 | $1,341 |
| Jardiance | 14 | $22,141 | $1,581 |
| Sevelamer Carbonate | 56 | $12,102 | $216 |
| Potassium Citrate Er | 54 | $8,221 | $152 |
| Clonidine | 37 | $7,365 | $199 |
| Bumetanide | 35 | $4,084 | $117 |
| Colchicine | 23 | $3,636 | $158 |
| Amlodipine Besylate | 254 | $3,130 | $12 |
| Doxazosin Mesylate | 104 | $2,839 | $27 |
| Nifedipine Er | 49 | $2,799 | $57 |
| Metoprolol | 102 | $2,744 | $27 |
| Felodipine Er | 53 | $2,717 | $51 |
| Calcium Acetate | 26 | $2,714 | $104 |
| Losartan | 145 | $2,362 | $16 |
| Labetalol | 32 | $2,354 | $74 |
| Midodrine | 15 | $2,124 | $142 |
| Pantoprazole | 87 | $2,036 | $23 |
| Olmesartan Medoxomil | 43 | $1,819 | $42 |
| Hydralazine | 52 | $1,658 | $32 |
| Carvedilol | 95 | $1,490 | $16 |
| Calcitriol | 76 | $1,474 | $19 |
| Torsemide | 26 | $1,379 | $53 |
| Tamsulosin | 54 | $1,352 | $25 |
| Potassium Chloride | 36 | $1,301 | $36 |
| Telmisartan | 17 | $1,289 | $76 |
| Atorvastatin | 95 | $1,270 | $13 |
| Lisinopril | 138 | $1,258 | $9 |
| Pregabalin | 12 | $1,069 | $89 |
| Valsartan | 22 | $1,041 | $47 |
| Diltiazem 24hr Er (Cd) | 11 | $1,039 | $94 |
| Allopurinol | 54 | $1,003 | $19 |
| Ondansetron Odt | 14 | $985 | $70 |
| Furosemide | 136 | $967 | $7 |
| Famotidine | 29 | $917 | $32 |
| Clopidogrel | 31 | $666 | $21 |
| Ramipril | 39 | $660 | $17 |
| Gabapentin | 32 | $639 | $20 |
| Rosuvastatin | 11 | $634 | $58 |
| Pravastatin | 21 | $401 | $19 |
| Lactulose | 14 | $311 | $22 |
| Lidocaine-Prilocaine | 17 | $300 | $18 |
| Hydrochlorothiazide | 71 | $285 | $4 |
| Glipizide Er | 11 | $215 | $20 |
| Benazepril | 31 | $211 | $7 |
| Metoprolol | 29 | $192 | $7 |
| Fluticasone Propionate | 12 | $192 | $16 |
| Clonidine | 11 | $182 | $17 |
| Citalopram Hbr | 13 | $166 | $13 |
| Spironolactone | 16 | $158 | $10 |
| Metoclopramide | 15 | $157 | $10 |
| Atenolol | 26 | $135 | $5 |
| Triamterene-Hydrochlorothiazid | 12 | $125 | $10 |
| Acetaminophen-Codeine | 13 | $110 | $8 |
| Cephalexin | 13 | $65 | $5 |
| Amoxicillin | 14 | $55 | $4 |
2020: 54 drugs
| Renvela | 41 | $77,099 | $1,880 |
| Sevelamer Carbonate | 48 | $24,918 | $519 |
| Demeclocycline | 11 | $9,439 | $858 |
| Potassium Citrate Er | 47 | $8,517 | $181 |
| Clonidine | 36 | $7,378 | $205 |
| Felodipine Er | 74 | $3,621 | $49 |
| Doxazosin Mesylate | 106 | $3,274 | $31 |
| Nifedipine Er | 47 | $2,886 | $61 |
| Metoprolol | 85 | $2,728 | $32 |
| Losartan | 117 | $2,623 | $22 |
| Labetalol | 33 | $2,544 | $77 |
| Amlodipine Besylate | 235 | $2,365 | $10 |
| Olmesartan Medoxomil | 43 | $2,230 | $52 |
| Calcium Acetate | 20 | $2,189 | $109 |
| Midodrine | 15 | $2,159 | $144 |
| Telmisartan | 21 | $1,817 | $87 |
| Calcitriol | 91 | $1,728 | $19 |
| Torsemide | 35 | $1,478 | $42 |
| Pantoprazole | 63 | $1,421 | $23 |
| Retacrit | 12 | $1,416 | $118 |
| Hydralazine | 42 | $1,301 | $31 |
| Bumetanide | 15 | $1,251 | $83 |
| Carvedilol | 81 | $1,214 | $15 |
| Potassium Chloride | 30 | $1,046 | $35 |
| Lisinopril | 117 | $975 | $8 |
| Atorvastatin | 73 | $908 | $12 |
| Diltiazem 24hr Er (Cd) | 19 | $844 | $44 |
| Furosemide | 108 | $838 | $8 |
| Ondansetron Odt | 17 | $836 | $49 |
| Tamsulosin | 33 | $783 | $24 |
| Famotidine | 34 | $737 | $22 |
| Ramipril | 44 | $705 | $16 |
| Lidocaine-Prilocaine | 30 | $671 | $22 |
| Allopurinol | 35 | $636 | $18 |
| Omeprazole | 19 | $595 | $31 |
| Benazepril | 52 | $583 | $11 |
| Clopidogrel | 35 | $500 | $14 |
| Nystatin | 17 | $439 | $26 |
| Pravastatin | 19 | $408 | $21 |
| Prednisone | 16 | $397 | $25 |
| Gabapentin | 24 | $396 | $16 |
| Levothyroxine | 11 | $345 | $31 |
| Fluoxetine | 13 | $323 | $25 |
| Clonidine | 13 | $311 | $24 |
| Hydrochlorothiazide | 55 | $259 | $5 |
| Metoprolol | 22 | $245 | $11 |
| Glipizide Er | 12 | $233 | $19 |
| Glipizide | 13 | $217 | $17 |
| Bupropion Xl | 13 | $209 | $16 |
| Spironolactone | 14 | $167 | $12 |
| Atenolol | 18 | $128 | $7 |
| Simvastatin | 12 | $106 | $9 |
| Cephalexin | 16 | $103 | $6 |
| Zolpidem | 12 | $74 | $6 |
2019: 51 drugs
| Renvela | 40 | $87,087 | $2,177 |
| Sevelamer Carbonate | 61 | $35,763 | $586 |
| Potassium Citrate Er | 39 | $7,893 | $202 |
| Clonidine | 25 | $7,053 | $282 |
| Demeclocycline | 15 | $5,123 | $342 |
| Felodipine Er | 67 | $3,749 | $56 |
| Nifedipine Er | 50 | $3,198 | $64 |
| Doxazosin Mesylate | 86 | $3,116 | $36 |
| Telmisartan | 23 | $2,661 | $116 |
| Labetalol | 37 | $2,481 | $67 |
| Bumetanide | 23 | $2,249 | $98 |
| Losartan | 120 | $2,136 | $18 |
| Metoprolol | 65 | $2,066 | $32 |
| Amlodipine Besylate | 211 | $2,055 | $10 |
| Midodrine | 22 | $2,027 | $92 |
| Olmesartan Medoxomil | 25 | $1,759 | $70 |
| Potassium Chloride | 30 | $1,667 | $56 |
| Pantoprazole | 52 | $1,553 | $30 |
| Calcium Acetate | 21 | $1,308 | $62 |
| Carvedilol | 76 | $1,224 | $16 |
| Calcitriol | 56 | $1,210 | $22 |
| Lisinopril | 107 | $1,057 | $10 |
| Atorvastatin | 51 | $1,034 | $20 |
| Gabapentin | 28 | $969 | $35 |
| Hydralazine | 28 | $957 | $34 |
| Valsartan | 12 | $893 | $74 |
| Tamsulosin | 37 | $854 | $23 |
| Famotidine | 36 | $818 | $23 |
| Duloxetine | 14 | $769 | $55 |
| Allopurinol | 38 | $744 | $20 |
| Furosemide | 103 | $720 | $7 |
| Ramipril | 44 | $706 | $16 |
| Benazepril | 45 | $636 | $14 |
| Ondansetron Odt | 11 | $596 | $54 |
| Pravastatin | 21 | $554 | $26 |
| Levothyroxine | 14 | $467 | $33 |
| Fluticasone Propionate | 28 | $432 | $15 |
| Ondansetron | 14 | $404 | $29 |
| Hydrochlorothiazide | 58 | $365 | $6 |
| Clopidogrel | 21 | $365 | $17 |
| Lidocaine-Prilocaine | 24 | $364 | $15 |
| Diltiazem 24hr Er (Cd) | 13 | $352 | $27 |
| Nystatin | 15 | $323 | $22 |
| Fluoxetine | 12 | $265 | $22 |
| Quetiapine | 11 | $260 | $24 |
| Simvastatin | 19 | $206 | $11 |
| Atenolol | 18 | $154 | $9 |
| Metoprolol | 17 | $153 | $9 |
| Spironolactone | 13 | $151 | $12 |
| Prednisone | 11 | $93 | $8 |
| Ciprofloxacin | 14 | $89 | $6 |
2018: 53 drugs
| Renvela | 73 | $135,338 | $1,854 |
| Sevelamer Carbonate | 97 | $75,834 | $782 |
| Clinisol | 93 | $14,615 | $157 |
| Potassium Citrate Er | 32 | $11,342 | $354 |
| Demeclocycline | 14 | $9,337 | $667 |
| Prosol | 52 | $6,788 | $131 |
| Nifedipine Er | 49 | $3,905 | $80 |
| Clonidine | 23 | $3,561 | $155 |
| Doxazosin Mesylate | 72 | $3,218 | $45 |
| Bumetanide | 25 | $2,989 | $120 |
| Metoprolol | 66 | $2,979 | $45 |
| Felodipine Er | 53 | $2,669 | $50 |
| Labetalol | 28 | $2,526 | $90 |
| Potassium Chloride | 40 | $2,227 | $56 |
| Midodrine | 31 | $2,106 | $68 |
| Calcium Acetate | 16 | $1,809 | $113 |
| Amlodipine Besylate | 218 | $1,807 | $8 |
| Calcitriol | 62 | $1,750 | $28 |
| Losartan | 112 | $1,566 | $14 |
| Valsartan | 33 | $1,469 | $45 |
| Hydralazine | 45 | $1,455 | $32 |
| Duloxetine | 16 | $1,321 | $83 |
| Pantoprazole | 54 | $1,244 | $23 |
| Lisinopril | 106 | $1,061 | $10 |
| Atorvastatin | 45 | $1,051 | $23 |
| Gabapentin | 38 | $985 | $26 |
| Ramipril | 45 | $847 | $19 |
| Carvedilol | 60 | $789 | $13 |
| Tamsulosin | 27 | $787 | $29 |
| Famotidine | 50 | $745 | $15 |
| Ultra-Fine Mini Pen Needle | 16 | $712 | $44 |
| Cartia Xt | 14 | $681 | $49 |
| Ondansetron | 19 | $598 | $31 |
| Allopurinol | 32 | $549 | $17 |
| Spironolactone | 21 | $546 | $26 |
| Furosemide | 90 | $532 | $6 |
| Benazepril | 38 | $504 | $13 |
| Fluticasone Propionate | 25 | $466 | $19 |
| Pravastatin | 13 | $382 | $29 |
| Atenolol | 35 | $379 | $11 |
| Hydrochlorothiazide | 67 | $358 | $5 |
| Clopidogrel | 18 | $332 | $18 |
| Bupropion | 11 | $317 | $29 |
| Clonidine | 25 | $314 | $13 |
| Metoprolol | 27 | $253 | $9 |
| Prednisone | 28 | $201 | $7 |
| Simvastatin | 17 | $191 | $11 |
| Glipizide | 12 | $148 | $12 |
| Quetiapine | 14 | $126 | $9 |
| Cephalexin | 14 | $123 | $9 |
| Alendronate | 12 | $77 | $6 |
| Ciprofloxacin | 11 | $71 | $6 |
| Zolpidem | 11 | $45 | $4 |
2017: 59 drugs
| Renvela | 119 | $232,873 | $1,957 |
| Sensipar | 90 | $229,475 | $2,550 |
| Renagel | 11 | $15,054 | $1,369 |
| Sevelamer Carbonate | 13 | $14,687 | $1,130 |
| Clinisol | 94 | $14,378 | $153 |
| Potassium Citrate Er | 33 | $13,661 | $414 |
| Clonidine | 34 | $6,689 | $197 |
| Prosol | 35 | $6,188 | $177 |
| Metoprolol | 68 | $3,410 | $50 |
| Nifedipine Er | 60 | $2,920 | $49 |
| Calcium Acetate | 26 | $2,681 | $103 |
| Novolin N | 11 | $2,520 | $229 |
| Doxazosin Mesylate | 72 | $2,294 | $32 |
| Valsartan | 55 | $2,175 | $40 |
| Labetalol | 28 | $2,093 | $75 |
| Amlodipine Besylate | 230 | $1,892 | $8 |
| Felodipine Er | 26 | $1,566 | $60 |
| Diltiazem 24hr Er | 18 | $1,487 | $83 |
| Atorvastatin | 54 | $1,247 | $23 |
| Calcitriol | 72 | $1,176 | $16 |
| Midodrine | 13 | $1,142 | $88 |
| Lisinopril | 115 | $1,128 | $10 |
| Potassium Chloride | 15 | $1,118 | $75 |
| Quinapril | 14 | $1,089 | $78 |
| Losartan | 86 | $963 | $11 |
| Tamsulosin | 26 | $958 | $37 |
| Hydralazine | 46 | $871 | $19 |
| Pantoprazole | 40 | $800 | $20 |
| Gabapentin | 35 | $626 | $18 |
| Famotidine | 73 | $603 | $8 |
| Levothyroxine | 14 | $598 | $43 |
| Carvedilol | 52 | $597 | $11 |
| Ultra-Fine Mini Pen Needle | 15 | $589 | $39 |
| Allopurinol | 35 | $578 | $17 |
| Furosemide | 111 | $509 | $5 |
| Fluticasone Propionate | 25 | $471 | $19 |
| Cartia Xt | 11 | $401 | $36 |
| Bumetanide | 11 | $388 | $35 |
| Benazepril | 34 | $357 | $11 |
| Ondansetron | 17 | $343 | $20 |
| Ramipril | 26 | $305 | $12 |
| Pravastatin | 13 | $295 | $23 |
| Quetiapine | 12 | $288 | $24 |
| Hydrochlorothiazide | 58 | $270 | $5 |
| Prednisone | 21 | $224 | $11 |
| Clopidogrel | 16 | $193 | $12 |
| Metoprolol | 25 | $190 | $8 |
| Spironolactone | 17 | $185 | $11 |
| Atenolol | 22 | $174 | $8 |
| Clonidine | 15 | $162 | $11 |
| Triamterene-Hydrochlorothiazid | 12 | $161 | $13 |
| Simvastatin | 22 | $147 | $7 |
| Alendronate | 12 | $111 | $9 |
| Cephalexin | 11 | $91 | $8 |
| Glipizide | 16 | $84 | $5 |
| Minoxidil | 11 | $82 | $7 |
| Azithromycin | 12 | $61 | $5 |
| Lamotrigine | 12 | $52 | $4 |
| Tramadol | 11 | $52 | $5 |
2016: 51 drugs
| Renvela | 123 | $243,450 | $1,979 |
| Sensipar | 93 | $170,501 | $1,833 |
| Clinisol | 137 | $18,916 | $138 |
| Potassium Citrate Er | 26 | $9,172 | $353 |
| Clonidine | 45 | $8,571 | $190 |
| Benicar | 11 | $6,965 | $633 |
| Demeclocycline | 11 | $6,720 | $611 |
| Valsartan | 75 | $3,107 | $41 |
| Metoprolol | 55 | $2,717 | $49 |
| Calcium Acetate | 31 | $2,633 | $85 |
| Nifedipine Er | 51 | $2,505 | $49 |
| Amlodipine Besylate | 233 | $2,251 | $10 |
| Diltiazem 24hr Er | 16 | $2,223 | $139 |
| Labetalol | 56 | $2,204 | $39 |
| Doxazosin Mesylate | 58 | $1,976 | $34 |
| Pantoprazole | 50 | $1,356 | $27 |
| Potassium Chloride | 23 | $1,309 | $57 |
| Lisinopril | 125 | $1,141 | $9 |
| Tamsulosin | 31 | $946 | $31 |
| Hydralazine | 39 | $931 | $24 |
| Quinapril | 12 | $901 | $75 |
| Losartan | 82 | $859 | $10 |
| Ramipril | 34 | $842 | $25 |
| Allopurinol | 40 | $777 | $19 |
| Gabapentin | 21 | $773 | $37 |
| Atorvastatin | 50 | $770 | $15 |
| Bd Ultra-Fine Pen Needle | 18 | $760 | $42 |
| Carvedilol | 64 | $726 | $11 |
| Felodipine Er | 11 | $673 | $61 |
| Famotidine | 46 | $668 | $15 |
| Furosemide | 136 | $642 | $5 |
| Benazepril | 49 | $580 | $12 |
| Fluticasone Propionate | 34 | $576 | $17 |
| Klor-Con 8 | 11 | $503 | $46 |
| Nitrofurantoin | 12 | $485 | $40 |
| Calcitriol | 25 | $459 | $18 |
| Bupropion | 12 | $377 | $31 |
| Hydrochlorothiazide | 72 | $359 | $5 |
| Omeprazole | 15 | $265 | $18 |
| Metoprolol | 32 | $234 | $7 |
| Triamterene-Hydrochlorothiazid | 13 | $230 | $18 |
| Prednisone | 22 | $211 | $10 |
| Hydrocodone-Acetaminophen | 11 | $203 | $18 |
| Atenolol | 21 | $201 | $10 |
| Clopidogrel | 23 | $161 | $7 |
| Simvastatin | 17 | $161 | $9 |
| Clonidine | 18 | $139 | $8 |
| Spironolactone | 14 | $102 | $7 |
| Temazepam | 11 | $95 | $9 |
| Azithromycin | 12 | $82 | $7 |
| Cephalexin | 11 | $61 | $6 |
2015: 49 drugs
| Renvela | 120 | $197,109 | $1,643 |
| Sensipar | 59 | $97,002 | $1,644 |
| Demeclocycline | 20 | $11,692 | $585 |
| Potassium Citrate Er | 23 | $7,970 | $347 |
| Benicar | 12 | $6,352 | $529 |
| Valsartan | 79 | $5,855 | $74 |
| Nexium | 12 | $5,378 | $448 |
| Vesicare | 12 | $4,486 | $374 |
| Clinisol | 24 | $3,446 | $144 |
| Metoprolol | 45 | $3,085 | $69 |
| Calcium Acetate | 36 | $2,623 | $73 |
| Doxazosin Mesylate | 59 | $2,463 | $42 |
| Clonidine | 13 | $2,293 | $176 |
| Nifedipine Er | 41 | $1,978 | $48 |
| Felodipine Er | 25 | $1,798 | $72 |
| Amlodipine Besylate | 178 | $1,660 | $9 |
| Labetalol | 26 | $1,479 | $57 |
| Ramipril | 51 | $1,276 | $25 |
| Potassium Chloride | 37 | $1,119 | $30 |
| Lisinopril | 128 | $1,035 | $8 |
| Tamsulosin | 27 | $1,010 | $37 |
| Carvedilol | 76 | $824 | $11 |
| Calcitriol | 42 | $701 | $17 |
| Levothyroxine | 17 | $693 | $41 |
| Furosemide | 114 | $692 | $6 |
| Telmisartan | 13 | $688 | $53 |
| Cartia Xt | 11 | $677 | $62 |
| Lidocaine-Prilocaine | 18 | $672 | $37 |
| Oxybutynin Chloride Er | 11 | $639 | $58 |
| Pantoprazole | 27 | $596 | $22 |
| Benazepril | 63 | $583 | $9 |
| Losartan | 84 | $575 | $7 |
| Omeprazole | 22 | $561 | $26 |
| Allopurinol | 35 | $519 | $15 |
| Hydrochlorothiazide | 85 | $466 | $5 |
| Hydralazine | 27 | $414 | $15 |
| Metoprolol | 42 | $349 | $8 |
| Atenolol | 29 | $323 | $11 |
| Fluticasone Propionate | 30 | $323 | $11 |
| Spironolactone | 19 | $288 | $15 |
| Gabapentin | 14 | $283 | $20 |
| Atorvastatin | 22 | $230 | $10 |
| Temazepam | 12 | $222 | $19 |
| Simvastatin | 19 | $185 | $10 |
| Famotidine | 16 | $175 | $11 |
| Hydrocodone-Acetaminophen | 12 | $158 | $13 |
| Cephalexin | 19 | $132 | $7 |
| Minoxidil | 16 | $115 | $7 |
| Prednisone | 16 | $99 | $6 |
2014: 54 drugs
| Renvela | 132 | $129,283 | $979 |
| Sensipar | 58 | $89,133 | $1,537 |
| Diovan | 88 | $28,202 | $320 |
| Sevelamer Carbonate | 22 | $22,366 | $1,017 |
| Nexium | 29 | $11,107 | $383 |
| Demeclocycline | 17 | $11,043 | $650 |
| Potassium Citrate Er | 19 | $6,843 | $360 |
| Nifedipine Er | 96 | $6,481 | $68 |
| Valsartan | 20 | $5,778 | $289 |
| Vesicare | 13 | $4,353 | $335 |
| Calcium Acetate | 38 | $4,141 | $109 |
| Clonidine | 26 | $3,388 | $130 |
| Metoprolol | 53 | $3,074 | $58 |
| Doxazosin Mesylate | 59 | $2,887 | $49 |
| Labetalol | 40 | $2,287 | $57 |
| Amlodipine Besylate | 202 | $2,120 | $10 |
| Midodrine | 22 | $2,034 | $92 |
| Ramipril | 51 | $1,730 | $34 |
| Felodipine Er | 20 | $1,679 | $84 |
| Clinisol | 13 | $1,667 | $128 |
| Lisinopril | 121 | $1,211 | $10 |
| Carvedilol | 103 | $1,153 | $11 |
| Losartan | 91 | $1,119 | $12 |
| Potassium Chloride | 34 | $1,025 | $30 |
| Hydralazine | 38 | $1,012 | $27 |
| Calcitriol | 67 | $952 | $14 |
| Sodium Polystyrene Sulfonate | 11 | $933 | $85 |
| Oxybutynin Chloride Er | 20 | $891 | $45 |
| Benazepril | 68 | $854 | $13 |
| Pantoprazole | 37 | $807 | $22 |
| Furosemide | 129 | $771 | $6 |
| Nifedical Xl | 21 | $757 | $36 |
| Omeprazole | 35 | $628 | $18 |
| Levothyroxine | 20 | $592 | $30 |
| Metoprolol | 59 | $591 | $10 |
| Hydrochlorothiazide | 100 | $571 | $6 |
| Tamsulosin | 30 | $565 | $19 |
| Hydrocodone-Acetaminophen | 14 | $537 | $38 |
| Lidocaine-Prilocaine | 18 | $521 | $29 |
| Simvastatin | 51 | $505 | $10 |
| Atenolol | 40 | $498 | $12 |
| Atorvastatin | 23 | $303 | $13 |
| Allopurinol | 38 | $298 | $8 |
| Gabapentin | 24 | $217 | $9 |
| Glipizide Er | 19 | $215 | $11 |
| Famotidine | 21 | $202 | $10 |
| Bumetanide | 15 | $186 | $12 |
| Terazosin | 11 | $133 | $12 |
| Glimepiride | 14 | $133 | $9 |
| Prednisone | 16 | $132 | $8 |
| Spironolactone | 13 | $130 | $10 |
| Minoxidil | 14 | $106 | $8 |
| Citalopram Hbr | 12 | $99 | $8 |
| Amoxicillin | 13 | $25 | $2 |
2013: 61 drugs
| Renvela | 139 | $111,511 | $802 |
| Sensipar | 85 | $75,010 | $882 |
| Diovan | 158 | $41,221 | $261 |
| Demeclocycline | 15 | $8,869 | $591 |
| Nifedipine Er | 119 | $8,064 | $68 |
| Potassium Citrate | 27 | $7,325 | $271 |
| Nexium | 16 | $6,676 | $417 |
| Calcium Acetate | 55 | $5,661 | $103 |
| Amlodipine Besylate | 213 | $3,053 | $14 |
| Metoprolol | 67 | $2,742 | $41 |
| Benicar | 13 | $2,612 | $201 |
| Premarin | 12 | $2,239 | $187 |
| Clonidine | 12 | $2,153 | $179 |
| Labetalol | 41 | $2,032 | $50 |
| Felodipine Er | 33 | $1,977 | $60 |
| Novolog | 12 | $1,841 | $153 |
| Micardis Hct | 13 | $1,801 | $139 |
| Doxazosin Mesylate | 70 | $1,755 | $25 |
| Midodrine | 16 | $1,721 | $108 |
| Hydralazine | 37 | $1,464 | $40 |
| Lansoprazole | 22 | $1,368 | $62 |
| Ramipril | 53 | $1,316 | $25 |
| Lisinopril | 130 | $1,313 | $10 |
| Carvedilol | 86 | $1,251 | $15 |
| Calcitriol | 61 | $1,193 | $20 |
| Losartan | 65 | $1,032 | $16 |
| Novolin N | 12 | $1,002 | $84 |
| Pantoprazole | 17 | $987 | $58 |
| Benazepril | 68 | $984 | $14 |
| Atorvastatin | 45 | $956 | $21 |
| Potassium Chloride | 14 | $936 | $67 |
| Oxybutynin Chloride Er | 18 | $931 | $52 |
| Nifedical Xl | 18 | $908 | $50 |
| Omeprazole | 19 | $832 | $44 |
| Furosemide | 121 | $712 | $6 |
| Lidocaine-Prilocaine | 26 | $701 | $27 |
| Simvastatin | 64 | $684 | $11 |
| Tamsulosin | 20 | $592 | $30 |
| Atenolol | 54 | $586 | $11 |
| Clopidogrel | 24 | $538 | $22 |
| Gabapentin | 28 | $530 | $19 |
| Hydrochlorothiazide | 84 | $432 | $5 |
| Diltiazem 24hr Cd | 13 | $391 | $30 |
| Fluticasone Propionate | 12 | $345 | $29 |
| Metoprolol | 36 | $333 | $9 |
| Levothyroxine | 26 | $329 | $13 |
| Famotidine | 24 | $309 | $13 |
| Insulin | 12 | $303 | $25 |
| Terazosin | 16 | $264 | $17 |
| Zolpidem | 37 | $264 | $7 |
| Diltiazem Er | 11 | $262 | $24 |
| Allopurinol | 40 | $259 | $6 |
| Spironolactone | 12 | $226 | $19 |
| Glipizide Er | 23 | $202 | $9 |
| Minoxidil | 14 | $197 | $14 |
| Glipizide | 11 | $181 | $16 |
| Prednisone | 27 | $163 | $6 |
| Clonidine | 11 | $133 | $12 |
| Glimepiride | 18 | $128 | $7 |
| Hydrocodone-Acetaminophen | 13 | $121 | $9 |
| Cephalexin | 11 | $81 | $7 |
Money from drug and device companies
$156 in 2025
| 2025 | 2 | 2 | None | $156 |
| 2023 | 1 | 1 | None | $19 |
| 2022 | 1 | 1 | None | $37 |
| 2021 | 1 | 1 | None | $20 |
| 2019 | 1 | 1 | None | $22 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Calliditas Therapeutics US | Tarpeyo | $125 | 1 payment
|
| NxStage Medical | Nxstage System One | $31 | 1 payment
|
See all 2 published payments
| NxStage Medical | Meals · 2025-08-29 | Nxstage System One | $31 |
| Calliditas Therapeutics US | Meals · 2025-03-03 | Tarpeyo | $125 |
See earlier years (2023, 2022, 2021, 2019)
2023: $19
| Baxter Healthcare | Renal - Pd | $19 | 1 payment
|
2022: $37
| Bayer HealthCare Pharmaceuticals | Kerendia | $37 | 1 payment
|
2021: $20
| Bayer HealthCare Pharmaceuticals | Kerendia | $20 | 1 payment
|
2019: $22
| Otsuka America Pharmaceutical | Jynarque | $22 | 1 payment
|
Professional record
- NPI
- 1689651820
- Licence
- CA G83906California G83906: Current · expires 2027-05-31
- Trained
- University of Wisconsin School of Medicine, 1991
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RN0300X (207RN0300X)
- Mailing address
- 2350 W El Camino Real, 2nd Floor, Mountain View, CA, 94040
- NPI first listed
- 2005-12-29
- NPI last updated
- 2011-12-01
This is when the NPI record was last certified, not a medical board exam.